Robbins LLP informs stockholders that a class action was filed against Cerevel Therapeutics Holdings, Inc. ("Cerevel" or the "Company"), Bain Capital Investors, LLC ("Bain") and Pfizer, Inc. ("Pfizer" ...
The Action was filed in the United States District Court for the District of Delaware and is captioned: S/M Merger Arbitrage, L.P. v. Cerevel Therapeutics Holdings, Inc., No. 25-cv-417 (D. Del.). The ...
Several private equity firms are studying DSM-Firmenich AG’s animal nutrition and health business, which could be valued at ...
The $150 million will also go toward Atsena’s preclinical pipeline and expand the use of the biotech’s spreading AAV.SPR ...
(Batesville, IN) – Hillenbrand, Inc. has announced that it has completed the previously announced sale of its majority interest in the Milacron injection molding and extrusion business (“Milacron”), ...
PeakAlts specializes in sourcing hard-to-access investments, performing institutional-grade diligence, and structuring terms ...
Hillenbrand completed the previously announced sale of its majority interest in the Milacron injection molding and extrusion ...
KKR will invest around $1.7 billion for a majority stake and JIC's private equity arm will invest $635 million for a minority ...
UK home and motor insurance firm Esure Group Plc sees further growth in the country after a £200 million ($258 million) ...
BOSTON, MA – American private investment firm Bain Capital is on the verge of acquiring a significant stake in Manappuram Finance, one of Kerala’s leading gold loan providers, in a deal valued ...
Hillenbrand (HI) announced that it has completed the previously announced sale of its majority interest in the Milacron injection molding and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback